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Abstract
There is growing recognition in the academic literature that critical decisions concerning resource allocation 
and resource management in health and care are influenced by a range of contextual factors. In their paper 
in this journal, Williams et al define these ‘decisions of value’ as being characterized by a significant and 
demonstrable impact on quality and resources in health and care. ‘Decisions of value’ are key functions of health 
and care organizations, yet relatively little is known about how contextual factors (such as different sources 
and types of evidence used, organizational context and decision-making structures, and the wider interests of 
patients, the public and politicians) influence those decisions. In this commentary we offer some reflections on 
our international experiences in capacity building, developing and implementing priority setting and resource 
allocation (PSRA) mechanisms in the health and care sectors in a range of low-, middle-, and high-income 
countries. We focus on the role of organizational culture, the relationship to government including political and 
regulatory environments, and the potential for patient and public engagement in PSRA mechanisms.
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There is growing recognition in the academic literature that critical decisions concerning resource allocation and resource management in health and care are 
influenced by a range of contextual factors. In their paper in 
this journal, Williams et al define these ‘decisions of value’ as 
being characterized by a significant and demonstrable impact 
on quality and resources in health and care.1 ‘Decisions of 
value’ are key functions of health and care organizations, yet 
relatively little is known about how contextual factors (such as 
different sources and types of evidence used, organizational 
context and decision-making structures, and the wider 
interests of patients, the public and politicians) influence 
those decisions. 
For the last 25 years or so, much of our own work has focused 
on building capacity in, and developing more rational and 
fair mechanisms for priority setting and resource allocation 
(PSRA) decisions in health and care at the meso and macro/
national levels. Although one of us trained as an economist, 
it seemed (at least to us) quite evident from very early on 
that decisions relating to value, quality and cost in health 
and care did not conform to the rigid and reductionist 
economists’ notion of ‘rational’ and evidence-based decision-
making. Instead, information on effectiveness and cost-
effectiveness seemed to be one important input in decision-
making processes, but there were many other important 
(and legitimate) influences on those processes. To better 
understand these influences, one needs to takes a wider 
view using lenses from a range of disciplines, including but 
not limited to psychology, management, ethics and political 
economy. Many of these influences fall under the umbrella of 
‘contextual factors.’
Williams et al make a strong addition to the literature on 
understanding how decisions relating to value in health and 
care are made in the real world. They do this by synthesizing 
the literature and providing an explanatory narrative around 
a range of contextual factors that influence decisions relating 
to value, cost and quality. They start by drawing a distinction 
between allocative decision-making processes (ie, those 
relating to the distribution of resources between alternative 
interventions and programmes) and technical decision-
making processes (ie, those relating to investments made in 
order to enhance organizational capacity and functioning). 
Following Pettigrew, they characterize factors in terms of 
inner context (factors from within the organization) and 
outer context (factors external to the organization).2 The 
findings of their review highlight some interesting clusters 
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of factors under each of these two broad groups. From the 
inner context, they identify sources of information (often 
clinical, ethical, and cost information), interests within 
the organization (including patients), organizational and 
institutional characteristics, governance and leadership and 
organizational culture. From the outer context, they identify 
external interests such as regulators, the media, and the public, 
economic factors, and relationship to government.
Several of the points the authors raise are particularly 
important, given our experiences in the development and 
implementation of PSRA mechanisms in the health and 
care sectors. First, the authors draw a distinction between 
‘organizational and institutional characteristics’ and 
‘organizational culture.’ We think this is a useful distinction to 
draw, and the authors are suitably circumspect about coming 
up with a clear definition of ‘organizational culture.’ Second, 
they discuss how the relationship to government including 
political and regulatory environments, can engender decision-
making that is driven by compliance and risk aversion rather 
than outcomes. One only needs to spend a very short period 
of time in the health system to see the powerful influence of 
compliance and risk aversion in decisions. Third, the authors 
conclude that where decisions affecting costs and quality are 
of significant scale and scope there is a strong normative case 
for involving patients and citizens. This is a point with which 
we agree, and has been a research focus of significant interest 
in the last decade. 
In what follows, we would like to offer some reflections on 
each of these three points. We have chosen to focus on these 
three points as they are particularly important in PSRA and 
allocative decision-making, as that is where our experience lies. 
These reflections draw on experiences we and international 
colleagues have had in developing and implementing PSRA 
decision processes in a number of countries over the last 
25 years, employing methods from economics, ethics and 
decision sciences.
An important message from our experiences in developing 
and implementing PSRA mechanisms is the need for health 
economists and decision analysts to be practical and not 
expect organizations, managers, and clinicians to simply 
take up ‘rational’ and evidence-based approaches to priority 
setting. For a PSRA approach to be effective, analysts and 
decision-makers also need to consider a range of pragmatic 
and ethical considerations.3,4 Pragmatic considerations reflect 
the practical challenges that managers and clinicians face in 
allocating resources, including establishing organisational 
objectives, understanding organisational context and 
ensuring organisational readiness, and ascertaining that the 
implementation of results is feasible.3,4
In our experience perhaps the strongest challenge to any 
‘rational’ and evidence-based approach to priority setting 
is that of organisational context and behaviour. Addressing 
issues such as the need for relative organisational stability 
(noting that flux is the norm rather than the exception in health 
services), the active involvement of high-level champions, an 
organisational culture that is receptive to fostering change, and 
an openness to learning are all critical factors to the success of 
evidence-based PSRA tools as practical decision-making aids. 
Effective management and leadership within health services 
is required to drive any PSRA process. The application of 
new priority-setting methods results in significant changes in 
decision-making culture, and potentially in the configuration 
of health and care services. At the same time, ownership by 
key stakeholders is necessary, including ownership by service 
managers/providers, and community/patient representatives. 
Providers will only own the process if they are involved from 
the outset and the process is internally driven. Similarly, 
there needs to be confidence that the chosen PSRA model 
will remain in place for some time and will be actively 
implemented.3,4 
Our own experiences with PSRA processes seem to have a 
lot in common with the findings of Williams et al, namely, 
that organizational culture is hard to define, it can be 
unpacked to a degree, and it intersects with a number of other 
contextual factors, including organizational characteristics. 
One potential way forward may come from the literature on 
high-performing health organizations,5 which Smith et al 
have employed to develop a framework of high performance 
in PSRA based on four domains of structures, processes, 
attitudes and behaviours, and outcomes.6
Turning to the second point, once again it only takes a 
short period of time working in health and care systems to 
understand that the political environment can lead to risk 
aversion in many areas of decision-making. This is perhaps 
most evident in coverage and disinvestment decisions. Many 
decision-makers involved in the adoption and coverage 
decisions of new interventions will have experienced a political 
volte face on priority-setting decisions, where (for example) the 
Minister and her/his team reverse a decision to limit access to 
a new intervention. This is perhaps most evident in decisions 
relating to access to drugs for rare diseases and cancer drugs 
for patients with last-stage disease. This is not a criticism as 
such, since decision reversals typically reflect the democratic 
political systems in which they are made, and the reality is that 
politicians are sensitive to their electorate and other interest 
groups and therefore may reverse ‘unpopular’ decisions. The 
same applies to disinvestment recommendations. Indeed, 
both decision-makers and politicians are typically highly risk 
averse to disinvestment decisions, even when ‘rational’ and 
evidence-based processes show an intervention is either of no 
value or is of low value and those resources could be redirected 
to interventions that provide greater value to the community. 
Indeed, in our experiences it seems quite a stretch to suggest 
that decision-makers and politicians value losses in the same 
way they value gains; it is quite evident that disinvestment 
decisions are often treated fundamentally differently from 
adoption and coverage decisions. 
Finally, to the third point: the normative case for involving 
patients and citizens. The last decade or so has seen a rapid 
increase in the development of methods and applications of 
both patient and public engagement in decisions of value in 
health and care. Our own interests lie mainly in deliberative 
public engagement, which we would suggest should have 
a growing role in determining what the most important 
consequences are of a funding decision. From a normative 
perspective, there is agreement among many stakeholders 
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that public engagement is necessary to realize the democratic 
ideals of legitimacy, transparency, and accountability.7 
Furthermore, these ideals have been advanced as necessary 
for supporting fair and ethical healthcare decision-making. 
On a more pragmatic level, public engagement can help 
stakeholders understand the degree of popular support for 
policy options, and may enhance public trust in decision-
making processes. One-way consultative methods such as 
focus groups or surveys have traditionally been used to elicit 
public preferences in these frameworks. However, deliberative 
forms of public engagement are emerging as a viable policy-
informing approach to civic participation in health and 
care decision-making. Specifically, deliberative public 
engagement involves members of the public in a process of 
learning and exchanging views explicitly directed towards 
collective problem-solving, thus making it distinct from other 
discussion-based consultation forums, like focus groups.8 We 
would suggest that deliberative public engagement methods 
have significant potential to inform ‘decisions of value’ in 
health and care. In particular, public engagement enhances 
accountability, may improve the legitimacy of decisions 
taken and can be used to work through moral conflict by 
creating platforms for shared decision-making on key policy 
issues.9 
Lastly, we would like to return to the influence of the political 
environment on decision-making and in particular on 
risk aversion. We have both had the privilege of teaching 
in a number of professional graduate programs in health 
administration and policy over the years. We have always 
found these courses to be immensely enjoyable, and have 
learnt a tremendous amount from students and other faculty 
about how decisions really play out in health and care systems. 
Indeed, we would recommend any academic health economist 
to audit one of these courses to gain a good understanding of 
how uni-dimensional the ‘rational’ health economics model 
of PSRA can be, and how many other contextual factors shape 
how decisions relating to value should be, and are, made.
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